Physician profile
Aashish Dua
NPI 1114961018
$188,823.53
in general payments reported to CMS, 2019-2025
36 companies · $16K in 2025
The $16K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $15K · 2021: $46K · 2022: $47K · 2023: $16K · 2024: $24K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $41K · Food and Beverage: $11K · Travel and Lodging: $3,916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,840.00 |
| Food and Beverage | $11,120.90 |
| Travel and Lodging | $3,916.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $94,682.50 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $42,586.55 | 2019-2025 | Lokelma, Farxiga, Andexxa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26,829.69 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $7,110.76 | 2019-2025 | |
| Angiodynamics, INC. | $5,494.29 | 2024-2025 | Angiovac, Alphavac |
| Penumbra, INC. | $2,077.99 | 2022 | |
| Medtronic, INC. | $1,709.88 | 2021-2025 | Resolute Onyx, Symplicity G3, In.Pact Admiral |
| Edwards Lifesciences Corporation | $1,383.76 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $1,205.84 | 2019-2025 | Watchman, Opticross, Avvigo Guidance System |
| Inari Medical, INC. | $833.88 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $781.52 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abiomed | $569.47 | 2020-2025 | Impella |
| Abbott Laboratories | $527.03 | 2019-2025 | Xact, Coroflow, Navitor |
| Cardiovascular Systems INC. | $507.25 | 2019-2023 | Diamondback Coronary |
| Heartflow, INC. | $402.46 | 2024-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $372.54 | 2020-2025 | |
| Medtronic Vascular, INC. | $337.30 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $168.87 | 2022-2025 | Eliquis, Camzyos |
| Terumo Medical Corporation | $140.93 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.22 | 2024-2025 | Jardiance |
| Amarin Pharma, INC. | $114.98 | 2019-2021 | |
| Scpharmaceuticals INC. | $112.22 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.26 | 2025 | |
| Amgen INC. | $106.56 | 2021-2025 | Repatha, Repatha |
| Cardiva Medical, INC. | $101.30 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Savvywire |
| Cagent Vascular INC | $87.16 | 2024 | Serrantor |
| Novo Nordisk INC | $79.63 | 2024-2025 | Wegovy, Ozempic |
| Chiesi USA, INC. | $55.37 | 2021-2023 | Kengreal |
| Daiichi Sankyo INC. | $52.56 | 2024-2025 | Injectafer |
| Actelion Pharmaceuticals US, INC. | $45.36 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Kestra Medical Technology Services, INC. | $30.37 | 2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $29.51 | 2023 | Optimizer |
| Teleflex LLC | $22.45 | 2023 | Manta |
| Acist Medical Systems, INC. | $19.99 | 2025 | |
| Glaxosmithkline, LLC. | $16.08 | 2025 | Shingrix, Arexvy |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aashish Dua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.